Undisclosed IL-20RB/IL-20 pathway inhibitor
/ Orion Corp
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 02, 2026
Blocking IL-20RB/IL-20 pathway enhances anti-tumour immune response in preclinical mouse tumour model.
(SITC 2026)
- No abstract available
Preclinical • Oncology • IL20RB
1 to 1
Of
1
Go to page
1